Form 4: Amkor Technology CEO Guillaume Rutten Executes Stock Option and Sells Shares
SEC Form 4 Filing
Amkor Technology's CEO, Guillaume Rutten, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 17, 2024, Guillaume Rutten, the President and CEO of Amkor Technology, Inc., exercised stock options to acquire 15,000 shares of common stock at a price of $14.17 per share.
- Simultaneously, Rutten sold 25,000 shares of Amkor Technology common stock at a weighted average price of $34.82 per share, with prices ranging from $34.59 to $35.00.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on November 8, 2023.
- Following these transactions, Rutten directly owns 94,476 shares of Amkor Technology common stock and options to acquire 38,125 shares.
- The stock option was granted on July 30, 2020, and vested in equal quarterly installments over three years.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
Insider transactions are common and closely monitored, especially those of key executives like the CEO. The use of a 10b5-1 plan suggests the transactions were pre-planned and not based on inside information.
Comparison to Industry Standards
- Comparing Rutten's transactions to other semiconductor company CEOs' trading activity would provide context.
- For example, monitoring similar Form 4 filings from executives at companies like Texas Instruments (TXN) or Intel (INTC) could offer a benchmark.
- Analyzing the frequency and size of these transactions relative to their holdings is important.
- The use of 10b5-1 plans is a common practice among executives to avoid accusations of insider trading, aligning with industry standards.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- However, the pre-planned nature of the sale mitigates concerns about insider information being used.
Key Dates
| Date | Description |
|---|---|
| 07/30/2020 | Date of grant for stock option to acquire 375,000 shares. |
| 10/30/2020 | Date stock options became exercisable. |
| 11/08/2023 | Date the Rule 10b5-1 trading plan was adopted. |
| 06/17/2024 | Date of stock option exercise and share sale. |
| 06/20/2024 | Date of Form 4 filing. |
| 07/30/2030 | Expiration date of the Employee Stock Option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.